These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23046235)

  • 21. Immunology and immunotherapy approaches for prostate cancer.
    Elkord E
    Prostate Cancer Prostatic Dis; 2007; 10(3):224-36. PubMed ID: 17420764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in small interfering RNA sensing by the immune system.
    Sioud M
    N Biotechnol; 2010 Jul; 27(3):236-42. PubMed ID: 20219711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harnessing the exosome-induced immune response for cancer immunotherapy.
    Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
    Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice.
    Jiang W
    Vaccine; 2012 Jan; 30(4):758-66. PubMed ID: 22133510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory RNA molecules in immunotherapy for cancer.
    Mao CP; Wu TC
    Methods Mol Biol; 2010; 623():325-39. PubMed ID: 20217561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(4):2665-76. PubMed ID: 10953341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antitumor immunity and cellular cancer therapies].
    Catros-Quemener V; Bouet F; Genetet N
    Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cell immunotherapy: mapping the way.
    Figdor CG; de Vries IJ; Lesterhuis WJ; Melief CJ
    Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current concepts in immunotherapy for the treatment of colorectal cancer.
    Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
    J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells in tumor immunology and immunotherapy.
    Turtle CJ; Hart DN
    Curr Drug Targets; 2004 Jan; 5(1):17-39. PubMed ID: 14738216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the code of innate immunity recognition of siRNAs.
    Sioud M
    Methods Mol Biol; 2009; 487():41-59. PubMed ID: 19301641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.
    Cannon MJ; O'Brien TJ; Underwood LJ; Crew MD; Bondurant KL; Santin AD
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):97-105. PubMed ID: 12113075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.
    Roses RE; Xu M; Koski GK; Czerniecki BJ
    Oncogene; 2008 Jan; 27(2):200-7. PubMed ID: 18176601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cell vaccines for cancer immunotherapy.
    Timmerman JM; Levy R
    Annu Rev Med; 1999; 50():507-29. PubMed ID: 10073291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cell-based cancer immunotherapies.
    Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cells in cancer immunotherapy.
    Gunzer M; Grabbe S
    Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.